WB, IHC-P, ICCmore details Unsuitable for:
Flow Cyt or IP
Synthetic peptide within Human Cdc6 aa 1-100 (N terminal). The exact sequence is proprietary. (Peptide available as ab197759)
WB: Hela treated with hydroxyurea and Raji treated with FBS lysates
IHC-P: Human gastric adenocarcinoma and Human breast carcinoma tissue
Mouse: We have preliminary internal testing data to indicate this antibody may not react with these species. Please contact us for more information.
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMab® patents
We are constantly working hard to ensure we provide our customers with best in class antibodies. As a result of this work we are pleased to now offer this antibody in purified format. We are in the process of updating our datasheets. The purified format is designated 'PUR' on our product labels. If you have any questions regarding this update, please contact our Scientific Support team.
This product is a recombinant rabbit monoclonal antibody.
Shipped at 4°C. Store at -20°C. Stable for 12 months at -20°C.
He Y et al. Cell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer Cells. PLoS One11:e0162633 (2016).
Read more (PubMed: 27611665) »
Huang J et al. miR-34a Modulates Angiotensin II-Induced Myocardial Hypertrophy by Direct Inhibition of ATG9A Expression and Autophagic Activity. PLoS One9:e94382 (2014).
Read more (PubMed: 24728149) »